Viacord Company Profile

08:49 EST 18th November 2017 | BioPortfolio

Being the leader in the cord blood banking and research and development industry means providing the highest quality service, care and science.

Since 1993 our dedication to care, and attention to every detail, has made ViaCord a leader in cord blood preservation. Along with our parent company ViaCell we continue to set the standards of cord blood preservation and to research new, life-saving applications utilizing stem cells. Explore this section to learn why more and more parents are choosing to bank their babies' umbilical cord blood with ViaCord.

Our Mission:

To provide the highest quality stem cell preservation service and care to our patients, families and their physicians. We at ViaCord believe these words are much more than just a promise. They are the commitment we live by.

Our Origins:

ViaCord was established in 1993 to give expectant parents an opportunity to bank their children's cord blood with comfort and security. Prior to launching our Cord Blood Banking Service, ViaCord conducted extensive research and validation studies to ensure that we set the highest standards regarding the collection, processing, and storage of cord blood. ViaCord worked closely with the following institutions during our development:

Obstetrics Program at Brigham and Women's Hospital in Boston, MA

The Children's Hospital in Boston, MA

The Christ Hospital in Cincinnati, OH

The University of Cincinnati's Hoxworth Blood Center


245 First Street
United States of America


Phone: 1-866-668-4895
Fax: 1-866-565-2243

News Articles [3 Associated News Articles listed on BioPortfolio]

ViaCord LLC Strategic SWOT Analysis Review [Report Updated: 22062017] Prices from USD $125

ViaCord LLC Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT anal...

Phase II Clinical Trial Data Establishes Effectiveness of using a Child’s Own Cord Blood to Treat Cerebral Palsy

Key Discoveries in the Therapeutic Application of Cord Blood: Improvement of Motor Function in Children with Cerebral Palsy Research published in Stem Cells Translation...

PerkinElmer Extends Clinical Whole Genome Sequencing Services

Provides Families a Novel, Personalized Approach to Managing their Health PerkinElmer, Inc., a global leader committed to innovating for a healthier world, expanded its...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]


Being the leader in the cord blood banking and research and development industry means providing the highest quality service, care and science. Since 1993 our dedication to care, and attention to ever...


ViaCell, Inc. is a biotechnology company dedicated to enabling the widespread application of human cells as medicine. The Company markets ViaCord®, a product offering through which families can prese...

More Information about "Viacord" on BioPortfolio

We have published hundreds of Viacord news stories on BioPortfolio along with dozens of Viacord Clinical Trials and PubMed Articles about Viacord for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Viacord Companies in our database. You can also find out about relevant Viacord Drugs and Medications on this site too.

Quick Search

Relevant Topic

Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Corporate Database Quicklinks

Searches Linking to this Company Record